证券代码：300020 证券简称：银江技术 编号：20220125 银江技术股份有限公司投资者关系活动记录表 | --- | --- | --- | |----------------|----------------------------------|--------------------------------------------------------| | | | | | 投资者关系活动 | ■特定对象调研 | □分析师会议 | | 类别 | □媒体采访 | □业绩说明会 | | | □新闻发布会 | □路演活动 | | | □现场参观 | | | | □其他（请文字说明其他活动内容） | | | 参与单位名称及 | | 财通证券、国家风险投资基金、来源发展、今越科技、米游科 | | 人员姓名 | 技、南鼎资产及个人投资者等共13人 | | | 时间 | 2022年1月25日 | | | 地点 | | 浙江省杭州市富阳区九龙大道中国智谷富春园区A1幢会议室 | | 上市公司接待人 | 董事、副总经理、董事会秘书 | 花少富先生； | | 员姓名 | 证券事务代表 | 吴孟立先生 | | | 1 ...

证券代码：300020 证券简称：银江技术 银江技术股份有限公司投资者关系活动记录表 编号：20220507 | --- | --- | --- | |-----------------------|------------------------------------------------------|---------------------------------------------------------| | | | | | 投资者关系活动 | □特定对象调研 | □分析师会议 | | 类别 | □媒体采访 | □业绩说明会 | | | □新闻发布会 | □路演活动 | | | □现场参观 | | | | ■其他（电话会议） | | | 参与单位名称及 | | 海通证券、中邮保险、建信信托、进门财经、名禹资产、卓财 | | 人员姓名 | 投资、明河投资、中域投资等共13人 | | | 时间 | 2022年5月7日 | | | 地点 | 电话会议 | | | 上市公司接待人 员姓名 | 董事、副总经理、董事会秘书 证券事务代表 吴孟立先生 | 花少富先生； | | | | | | | | 20 ...

证券代码：300020 证券简称：银江技术 编号：20220513 银江技术股份有限公司投资者关系活动记录表 | --- | --- | --- | |-----------------------|--------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------| | | | | | 投资者关系 | ■特定对象调研 | □分析师会议 | | 活动类别 | □媒体采访 | □业绩说明会 | | | □新闻发布会 | □路演活动 | | | | ■现场参观 □其他（请文字说明其他活动内容） | | 参与单位名称 | | 财通证券、国泰君安、中泰证券、证券日报、同花顺、大象咨 | | | | | | 及人员姓名 | | 询、俊皓集团、九禄投资及个人投资者等共21人 | | 时间 | 2022年5月13日，14:30-1 ...

Financial Performance - The company's revenue for Q3 2022 was ¥351,755,160.97, a decrease of 11.98% compared to the same period last year[3] - The net profit attributable to shareholders was ¥9,948,745.95, down 16.38% year-on-year[3] - The net profit excluding non-recurring gains and losses was ¥8,576,221.49, an increase of 18.82% compared to the same period last year[3] - Basic earnings per share were ¥0.01, a decrease of 50.00% compared to the same period last year[3] - Total operating revenue for Q3 2022 was CNY 1,280,533,526.90, a decrease of 14.06% compared to CNY 1,489,652,416.08 in the same period last year[17] - Net profit for Q3 2022 was CNY 77,521,091.30, a decline of 25.4% compared to CNY 103,902,551.36 in Q3 2021[18] - The total comprehensive income for the third quarter was CNY 78,904,538.14, compared to CNY 5,477,979.36 in the previous year, indicating a significant increase[19] - The company reported a basic and diluted earnings per share of CNY 0.12, down from CNY 0.16 in the previous year[19] Cash Flow and Assets - The operating cash flow net amount for the year-to-date was ¥79,480,490.75, showing a significant increase of 118.49%[3] - As of September 30, 2022, the company's cash and cash equivalents amount to RMB 191,113,534.07, a decrease from RMB 425,997,510.12 at the beginning of the year[14] - The company's cash and cash equivalents were not explicitly stated but can be inferred from the decrease in current assets, which totaled CNY 4,289,762,779.37, down from CNY 4,488,279,292.89[16] - The total cash and cash equivalents at the end of the period were CNY 129,985,530.82, a decrease from CNY 287,360,389.44 at the end of the previous year[22] - The cash inflow from operating activities totaled CNY 1,523,835,311.87, while cash outflow was CNY 1,444,354,821.12, leading to a net cash inflow[22] - The total cash inflow from financing activities was CNY 1,438,658,878.60, while the cash outflow was CNY 1,680,022,786.34, resulting in a net cash flow of CNY -241,363,907.74[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥6,471,116,615.88, a decrease of 1.79% from the end of the previous year[3] - The company's total assets as of Q3 2022 amounted to CNY 6,471,116,615.88, a decrease from CNY 6,589,119,675.96 at the end of the previous quarter[16] - Total liabilities decreased to CNY 2,931,027,863.29 in Q3 2022 from CNY 3,109,008,989.34 in the previous quarter[16] - The total equity attributable to shareholders of the parent company increased to CNY 3,513,237,740.30 from CNY 3,450,812,699.29[16] Shareholder Information - The total number of common shareholders at the end of the reporting period is 50,464[10] - The largest shareholder, Yinjian Technology Group Co., Ltd., holds 12.49% of shares, amounting to 81,883,007 shares, with 81,500,000 shares pledged[10] - The top ten shareholders include both institutional and individual investors, with significant holdings by Yinjian Technology Group and other individuals[10] - The total number of shares held by the top ten unrestricted shareholders is 81,883,007 shares, primarily held by Yinjian Technology Group and other individual shareholders[10] - The company has engaged in margin trading, with several shareholders participating through credit accounts[10] Research and Development - The company reported a significant increase in research and development expenditures, indicating a focus on innovation[8] - Research and development expenses for Q3 2022 were CNY 43,635,098.64, slightly down from CNY 44,360,724.07 in the same period last year[18] - The company experienced a significant increase in development expenditures, which rose to CNY 61,044,859.25 from CNY 27,020,372.27 in the previous quarter[16] Investment and Financing Activities - The company plans to raise up to RMB 1 billion through a private placement of A-shares, with net proceeds intended for the "Urban Brain" solution development and implementation project, a smart hospital project, and to supplement working capital[12] - The company experienced a reduction in investment income due to the disposal of equity in an associate during the reporting period[8] - Investment activities resulted in a net cash outflow of CNY -62,373,906.84, a decrease from a net inflow of CNY 235,947,087.28 in the previous year[22] Other Information - The company has implemented a stock option incentive plan, with adjustments made to the plan's exercise price and the number of options granted[11] - The company is currently in the review and inquiry stage with the Shenzhen Stock Exchange regarding its private placement application[12] - The company has not disclosed any changes in restricted shares during the reporting period[11] - The company did not conduct any audited review of the third-quarter report[23]

Financial Performance - The company's operating revenue for the first half of 2022 was ¥928,778,365.93, a decrease of 14.79% compared to ¥1,090,024,803.53 in the same period last year[23]. - The net profit attributable to shareholders of the listed company was ¥70,019,320.39, down 25.66% from ¥94,184,732.67 in the previous year[23]. - The basic earnings per share decreased by 21.43% to ¥0.11 from ¥0.14 in the previous year[23]. - The net profit after deducting non-recurring gains and losses was ¥71,646,285.33, a decrease of 12.03% from ¥81,439,603.44 in the same period last year[23]. - The company's operating revenue for the reporting period was ¥928,778,365.93, a decrease of 14.79% compared to ¥1,090,024,803.53 in the same period last year[47]. - The company's operating costs decreased by 15.48% to ¥685,222,993.69 from ¥810,756,389.89 year-on-year[47]. - The net profit for the first half of 2022 was CNY 68,172,345.35, a decline of 26.00% from CNY 92,125,068.63 in the first half of 2021[135]. - The total comprehensive income for the first half of 2022 was ¥99.51 million, a decrease from ¥121.27 million in the same period of 2021[139]. Cash Flow and Assets - The net cash flow from operating activities was ¥1,073,372.89, a significant improvement from a negative cash flow of ¥388,425,094.25 in the same period last year, representing a 100.28% increase[23]. - The cash and cash equivalents decreased to ¥222,367,280.44, representing 3.44% of total assets, down from 6.47% at the end of the previous year[52]. - The company's cash and cash equivalents decreased to CNY 177,887,767.92 from CNY 398,970,236.27, representing a decline of 55.54%[132]. - The ending balance of cash and cash equivalents was ¥158.04 million, down from ¥354.24 million at the end of the first half of 2021[142]. - The total current assets decreased from ¥4,488,279,292.89 at the start of 2022 to ¥4,376,032,268.61 by June 30, 2022, a reduction of approximately 2.5%[127]. - The company's total assets decreased from ¥6,589,119,675.96 at the start of 2022 to ¥6,468,141,905.85 by June 30, 2022, a decrease of approximately 1.8%[129]. Investments and R&D - Research and development expenses were ¥56,702,320.50, down 7.31% from ¥61,172,566.10 in the previous year[48]. - The company reported a total of 243 patents as of June 30, 2022, with 6 new patents granted in the first half of 2022[45]. - The company has successfully implemented over 3,000 smart hospital projects nationwide, with new projects launched in Xiamen, Zhumadian, and Ningbo during the reporting period[38]. - The company is advancing its product technology upgrades, focusing on the transportation sector and enhancing its green wave online product[39]. - The company is actively exploring cloud-based service tools and remote deployment to mitigate the impact of COVID-19 on project delivery and reduce costs[32]. Risks and Challenges - The company faces risks including policy risks, core personnel turnover risks, and risks related to business model innovation[4]. - In the first half of 2022, the global COVID-19 pandemic significantly impacted the company's order acquisition and business operations, leading to increased project implementation costs[70]. - The company has faced challenges such as weakened customer demand and extended accounts receivable collection periods due to the pandemic[70]. Shareholder Information - The company plans not to distribute cash dividends or issue bonus shares for this period[4]. - The total cash dividend distributed to shareholders for the 2021 fiscal year amounted to CNY 22,952,618.01 (including tax)[85]. - The company granted 14.72 million stock options to 247 incentive targets under its stock option incentive plan[79]. - The total number of shares outstanding is 655,789,086, with 95.65% being unrestricted shares[111]. Corporate Governance - The company has established a talent management and incentive system to mitigate the risk of core personnel turnover[68]. - The company is focusing on optimizing its business model by balancing existing and new business segments to reduce innovation risks[69]. - The company has not faced any administrative penalties related to environmental issues during the reporting period[85]. - There were no significant litigation or arbitration matters during the reporting period[94]. Future Outlook - The company plans to enhance project planning and risk mitigation strategies while improving its rapid delivery and remote deployment capabilities[70]. - The management expressed optimism about future performance, aiming for a revenue growth target of 10% for the next fiscal year[151]. - The company plans to enhance its market expansion strategies and invest in new technology development to drive future growth[151].

Financial Performance - The company's operating revenue for 2021 was CNY 1,999,686,204.20, a decrease of 6.48% compared to CNY 2,138,181,930.27 in 2020[22] - The net profit attributable to shareholders for 2021 was CNY 98,973,352.30, down 37.24% from CNY 157,704,491.11 in 2020[22] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 76,646,215.16, a decline of 43.88% from CNY 136,571,286.96 in 2020[22] - The net cash flow from operating activities was negative CNY 260,368,904.13, worsening by 184.58% compared to negative CNY 91,492,084.57 in 2020[22] - The basic earnings per share for 2021 was CNY 0.15, a decrease of 37.50% from CNY 0.24 in 2020[22] - The total assets at the end of 2021 were CNY 6,589,119,675.96, a decrease of 1.85% from CNY 6,713,578,738.66 at the end of 2020[22] - The net assets attributable to shareholders at the end of 2021 were CNY 3,450,812,699.29, down 0.64% from CNY 3,472,927,540.91 at the end of 2020[22] - The company reported a significant decline in revenue from the Northeast region by 17.55%, while the Southwest region saw an increase of 8.25%[75] - The company's total operating revenue for 2021 was ¥1,999,686,204.20, a decrease of 6.48% compared to ¥2,138,181,930.27 in 2020[71] - The net profit attributable to shareholders was ¥98,973,352.30, down 37.24% year-on-year, while the net profit after deducting non-recurring gains and losses was ¥76,646,215.16, a decline of 43.88%[71] Revenue Segmentation - Revenue from smart transportation was ¥946,451,480.45, accounting for 47.33% of total revenue, while revenue from smart healthcare increased by 4.41% to ¥348,720,270.92, representing 17.44% of total revenue[74] - The revenue from smart transportation was CNY 946,451,480.45, down 6.28% year-on-year, while the gross margin improved slightly to 29.96%[77] - The smart healthcare segment saw a revenue increase of 4.41% to CNY 348,720,270.92, with a gross margin of 34.29%[77] - The smart city segment experienced a revenue decline of 12.18% to CNY 677,693,654.60, with a gross margin of 14.67%[77] Strategic Initiatives - The company is positioned as a "city brain" operator, focusing on traffic control and grassroots governance, which aligns with national policies promoting digital transformation in urban management[34] - The "14th Five-Year Plan" emphasizes new infrastructure investment in the transportation sector, which is expected to drive demand for the company's services[33] - Nearly 500 cities in China have initiated "city brain" construction plans, with investments exceeding hundreds of billions, indicating a growing market opportunity[35] - The company aims to leverage data governance and urban management innovations to enhance its service offerings and capture market growth[36] - The strategic focus on digital economy and smart city solutions positions the company favorably for future growth in the evolving urban landscape[37] - The company aims to enhance AI-enabled traffic governance, with successful implementations in cities like Nanchang, Xichang, and Liaoyuan[47] - The investment scale for smart city projects, including "City Brain," is expected to reach CNY 100 billion during the 14th Five-Year Plan period[40] - The company is focusing on building a comprehensive "one network management" system to improve cross-departmental collaboration and data integration[41] Research and Development - Research and development expenses increased by 48.66% to CNY 106,639,311.66, reflecting the company's commitment to innovation[82] - The company's R&D investment amounted to ¥141,877,409.12 in 2021, representing 7.09% of its operating revenue, an increase from 4.27% in 2020[89] - The number of R&D personnel increased to 252 in 2021, accounting for 39.25% of the total workforce, a slight decrease from 39.45% in 2020[88] - The capitalized R&D expenditure for 2021 was ¥29,441,879.77, which constituted 20.75% of the total R&D investment[89] Market Expansion and Partnerships - The company has established strategic partnerships with major entities such as China Mobile, China Telecom, and Zhejiang University to enhance its digital governance initiatives[56] - The company has expanded its market presence to 20 regions across various provinces including Zhejiang, Anhui, and Sichuan, anticipating strong business growth in 2022[57] - The company is actively pursuing new product development and technological advancements to enhance its service offerings[129] - The management team has emphasized a strategic focus on market expansion and potential mergers and acquisitions to drive growth[129] Corporate Governance - The company has held five shareholder meetings in 2021, ensuring equal rights for all shareholders and maintaining transparency in its operations[116] - The board of directors consists of nine members, including three independent directors, complying with legal and regulatory requirements[117] - The company has implemented a strategic plan to enhance its talent acquisition and management processes, recognizing talent as a core competitive advantage[109] - The company has a dedicated financial department and independent financial decision-making processes[120] - The company has implemented a stock option incentive plan for 2021, which was discussed in the fourth temporary shareholder meeting[123] Risk Management - The company faces various risks including policy risks, core personnel turnover risks, and uncertainties in its business model[5] - The company has established a robust internal control and risk management system to address challenges arising from its expanding scale[111] - The company emphasizes compliance with laws and regulations, ensuring timely and accurate information disclosure to enhance transparency and credibility[164] Social Responsibility - The company actively fulfills its corporate social responsibilities while creating value for shareholders[163] - The company is committed to legal operations, actively paying taxes and supporting local economic development[164] - The company focuses on employee welfare, optimizing work environments and providing regular bonuses to enhance employee satisfaction and safety[164]

Financial Performance - The company's revenue for Q1 2022 was ¥508,969,316.12, a slight increase of 0.24% compared to ¥507,725,465.84 in the same period last year[3] - Net profit attributable to shareholders decreased by 13.36% to ¥50,006,253.77 from ¥57,717,285.51 year-on-year[3] - The net profit after deducting non-recurring gains and losses increased by 7.07% to ¥49,477,765.96 compared to ¥46,209,771.29 in the previous year[3] - The basic earnings per share decreased by 11.11% to ¥0.08 from ¥0.09 in the same period last year[3] - The diluted earnings per share also decreased by 11.11% to ¥0.08 from ¥0.09 year-on-year[3] - The weighted average return on equity was 1.44%, down from 1.64% in the previous year[3] - Total operating revenue for Q1 2022 was CNY 508,969,316.12, a slight increase from CNY 507,725,465.84 in Q1 2021, representing a growth of 0.25%[21] - Net profit for Q1 2022 was CNY 48,893,784.29, down from CNY 56,759,176.03 in the same period last year, indicating a decline of about 13.3%[22] - Earnings per share (basic and diluted) for Q1 2022 were both CNY 0.08, compared to CNY 0.09 in Q1 2021[23] - The total comprehensive income for Q1 2022 was CNY 48,893,784.29, down from CNY 74,447,944.03 in the previous year, indicating a decline of about 34.3%[22] Cash Flow - The net cash flow from operating activities improved significantly, reaching -¥61,845,978.71, an 84.40% increase from -¥396,391,183.96 in the same period last year[3] - The cash inflow from operating activities for the current period was ¥702,950,222.23, an increase of 14.8% compared to ¥612,220,885.86 in the previous period[24] - The total cash outflow from operating activities was ¥764,796,200.94, a decrease of 24.2% from ¥1,008,612,069.82 in the previous period[24] - The total cash inflow from operating activities included ¥603,666,311.05 from sales of goods and services, an increase from ¥546,354,338.79 in the previous period[24] - The cash inflow from investment activities was ¥16,000,000.00, a decrease of 91.9% from ¥197,476,300.00 in the previous period[26] - The net cash flow from investment activities was ¥14,307,942.61, down from ¥196,126,531.45 in the previous period[26] - The cash inflow from financing activities was ¥450,564,942.79, a decrease of 2.6% compared to ¥461,319,562.79 in the previous period[26] - The net cash flow from financing activities was -¥173,898,376.55, worsening from -¥156,340,900.63 in the previous period[26] - The ending balance of cash and cash equivalents was ¥132,806,442.00, down from ¥277,243,600.71 in the previous period[26] Assets and Liabilities - Total assets at the end of the reporting period were ¥6,480,477,730.94, a decrease of 1.65% from ¥6,589,119,675.96 at the end of the previous year[3] - Total liabilities decreased to CNY 2,951,473,260.03 from CNY 3,109,008,989.34, reflecting a reduction of about 5.08%[19] - Shareholders' equity attributable to the parent company increased by 1.45% to ¥3,500,818,953.06 from ¥3,450,812,699.29 at the end of the previous year[3] - The total current assets decreased from CNY 4,488,279,292.89 at the beginning of the year to CNY 4,393,882,999.58 by the end of the quarter, reflecting a decline of approximately 2.1%[17] - Cash and cash equivalents dropped significantly from CNY 425,997,510.12 to CNY 228,692,696.51, a decrease of about 46.3%[17] - Accounts receivable increased slightly from CNY 1,891,057,204.26 to CNY 1,892,482,584.41, indicating a growth of approximately 0.1%[17] - Inventory rose from CNY 39,601,069.70 to CNY 54,169,769.85, marking an increase of about 36.7%[17] - The long-term equity investment increased from CNY 589,944,044.61 to CNY 591,982,868.36, reflecting a growth of approximately 0.3%[17] Investments and Projects - The company reported non-recurring gains of ¥528,487.81, primarily from government subsidies and other income[5] - The company is involved in the PPP project for the Shenyang Regional Population Health Information Platform, which was officially launched in December 2019 and is currently in its second year of operation[13] - The company has a contract worth CNY 27,580,000 for the Yunnan Huaping to Lijiang Expressway project, which is currently in the debugging phase[13] - The company received CNY 65,126,182.21 from the sale of equity in Yibang International as of the first quarter of 2022[14] - The company reported investment income of CNY 2,038,823.75, up from CNY 1,618,807.37, representing a growth of approximately 25.9%[22] Research and Development - Research and development expenses for Q1 2022 were CNY 7,479,962.26, slightly up from CNY 7,245,382.00 in Q1 2021, indicating an increase of about 3.24%[21] Stock and Audit - The company reported a total of 28,616,623 shares under lock-up, with 27,813,840 shares classified as post-IPO restricted shares[12] - The company has implemented a stock option incentive plan, with the first grant registration completed on January 4, 2022[14] - The company did not conduct an audit for the first quarter report[27]

| --- | --- | --- | |------------------------|--------------------------------------------------------------------------|----------| | | | | | 证券代码： | 300020 证券简称：银江技术 公告编号： | 2022-020 | | | 银江技术股份有限公司 | | | | 关于举办投资者接待日活动的公告 | | | | 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 | | | 误导性陈述或重大遗漏。 | | | 为提高银江技术股份有限公司（以下简称"公司"）投资者关系管理的水平， 以更好地与投资者进行沟通交流，使广大投资者深入全面地了解公司情况，公司 将举办投资者接待日活动，现将有关事项公告如下： 一、接待时间 2022 年 5 月 13 日（星期五）下午 14:30-16:30。 二、接待地点 浙江省杭州市富阳区九龙大道中国智谷富春园区 A2 幢三楼会议室 。 三、预约方式 参与投资者请于 2022 年 5 月 11 日至 5 月 12 ...

Financial Performance - The company's revenue for Q3 2021 was ¥399,627,612.55, representing a 4.15% increase year-over-year[3] - Net profit attributable to shareholders decreased by 25.18% to ¥11,897,691.52 for the same period[3] - The net profit excluding non-recurring gains and losses dropped by 50.29% to ¥7,217,537.74[3] - Total operating revenue for Q3 2021 was CNY 1,489,652,416.08, a slight increase of 1.8% compared to CNY 1,473,162,292.26 in Q3 2020[23] - Net profit for Q3 2021 was CNY 103,902,551.36, down 19.1% from CNY 128,494,402.70 in Q3 2020[24] - The total comprehensive income attributable to the parent company for the third quarter was CNY 7,657,852.19, compared to CNY 299,556,629.75 in the previous period[25] - Basic and diluted earnings per share for the quarter were CNY 0.16, down from CNY 0.20 in the previous period[25] Assets and Liabilities - The total assets at the end of the reporting period were ¥6,506,760,944.41, a decrease of 3.08% compared to the end of the previous year[3] - The company's total assets as of September 30, 2021, were CNY 6,506,760,944.41, a decrease from CNY 6,713,578,738.66 at the end of 2020[20] - Current assets totaled CNY 4,669,951,089.82, an increase from CNY 4,492,838,641.53 at the end of 2020, representing a growth of 4.0%[19] - Total liabilities decreased to CNY 3,000,319,357.95 from CNY 3,208,025,672.37, indicating a reduction of 6.5%[21] Cash Flow - The cash flow from operating activities showed a negative net amount of ¥429,894,973.13, a decline of 121.68% year-to-date[3] - The net cash flow from operating activities was negative CNY 429,894,973.13, worsening from negative CNY 193,925,726.47 in the same period last year[28] - Cash inflow from operating activities totaled CNY 1,641,710,304.89, down from CNY 1,681,090,995.07 year-on-year[26] - Cash outflow from operating activities increased to CNY 2,071,605,278.02, compared to CNY 1,875,016,721.54 in the previous year[28] - The net cash flow from investing activities was CNY 235,947,087.28, significantly up from CNY 1,860,129.31 in the previous period[28] - Cash inflow from financing activities was CNY 1,528,235,384.71, down from CNY 1,667,948,941.44 year-on-year[28] - The net cash flow from financing activities was negative CNY 152,540,878.56, compared to a positive CNY 86,312,808.13 in the same period last year[28] - The ending cash and cash equivalents balance was CNY 287,360,389.44, down from CNY 455,286,764.84 in the previous year[28] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 42,893[10] - The company reported a total of 113,057,607 shares held by its controlling shareholder, Yinjian Technology Group Co., Ltd., representing 100% of the unrestricted shares[11] - The top ten unrestricted shareholders collectively hold 31,559,300 shares, accounting for 4.2413% of the total shares[14] - The company has a total of 28,500,321 restricted shares, which remain locked due to executive lock-up agreements[14] - The report indicates that the company’s major shareholders are involved in margin trading, which may affect share liquidity[11] Operational Developments - The company is currently involved in the implementation of the PPP project for the Shenyang Regional Population Health Information Platform, which officially began operations in December 2019[15] - The company has signed a contract for the Yunnan Huaping to Lijiang Expressway project, with a contract value of RMB 27,580 million, and is currently in the deep implementation phase[15] - The company is also working on the new railway station and related construction projects with a contract value of RMB 53.21 million, which is in the deep implementation stage[16] Research and Future Outlook - Research and development expenses for Q3 2021 were CNY 44,360,724.07, compared to CNY 40,928,642.33 in Q3 2020, reflecting a year-over-year increase of 8.5%[24] - The company has not disclosed any new product developments or technological advancements in this report[13] - There is no mention of market expansion or mergers and acquisitions in the current report[13] - The company has not provided specific future outlook or performance guidance in this report[13] Audit Information - The company did not undergo an audit for the third quarter report[30]

Financial Performance - The company's operating revenue for the first half of 2021 was approximately ¥1.09 billion, a slight increase of 0.05% compared to ¥1.09 billion in the same period last year[19]. - The net profit attributable to shareholders decreased by 18.45% to approximately ¥94.18 million, down from ¥115.49 million in the previous year[19]. - The net profit after deducting non-recurring gains and losses was approximately ¥81.44 million, a decrease of 13.41% compared to ¥94.05 million in the same period last year[19]. - The basic earnings per share fell by 22.22% to ¥0.14, down from ¥0.18 in the previous year[19]. - The total assets at the end of the reporting period were approximately ¥6.59 billion, a decrease of 1.85% from ¥6.71 billion at the end of the previous year[19]. - The net assets attributable to shareholders increased by 0.73% to approximately ¥3.50 billion, compared to ¥3.47 billion at the end of the previous year[19]. - The company reported a net cash flow from operating activities of approximately -¥388.43 million, a decline of 1.85% from -¥381.35 million in the same period last year[19]. - The weighted average return on equity decreased to 2.70%, down from 3.45% in the previous year[19]. - The company's revenue for the reporting period was CNY 1,090,024,803.53, a slight increase of 0.05% compared to CNY 1,089,444,158.29 from the previous year[48]. - Research and development expenses increased significantly by 84.44% to CNY 61,172,566.10, up from CNY 33,165,764.64 in the previous year[49]. - The company reported a substantial increase of 13,854.46% in net cash flow from investing activities, amounting to CNY 238,477,763.88, primarily due to exits from industrial funds[49]. - The total liabilities of the company were RMB 3,060,657,990.41, down from RMB 3,208,025,672.37, indicating a decrease of approximately 4.61%[132]. - The company's total comprehensive income for the first half of 2021 was CNY 121,268,378.40, compared to CNY 118,537,065.06 in the same period of 2020[144]. Strategic Initiatives - The company has established a three-in-one development strategy focusing on "system construction + product delivery + operation services" in the AI and IoT sectors, particularly in smart traffic, smart health, and smart cities[27]. - The company is pioneering a digital governance platform for grassroots management, utilizing AI, IoT, and big data to enhance social governance capabilities at the town and street levels[34]. - The HERO traffic signal machine has been certified by the Ministry of Public Security and is capable of seamless integration with the company's self-developed control cloud platform[32]. - The company has developed a comprehensive traffic signal control system that integrates AI algorithms and big data processing capabilities, improving data quality and reducing real-time data fusion time[30]. - The company has successfully implemented AI-enabled traffic governance solutions in cities like Hangzhou, Nanchang, and Taiyuan, enhancing traffic management in congested areas such as hospitals and schools[28]. - The digital operation services for urban traffic governance have been expanded to second and third-tier markets, with a focus on customized solutions based on local traffic characteristics[29]. - The company has developed a comprehensive IoT hospital framework, integrating various systems for unified management, which aims to reduce errors associated with traditional manual processes[37]. - Collaboration with Huawei has evolved into strategic ecological cooperation, resulting in the launch of IoT smart hospital solutions and significant market response, including the establishment of the first all-scenario smart hospital in Guangdong[38]. - The company aims to transform into a city brain operation service provider by leveraging AI, big data, and IoT technologies[74]. Risk Management - The company faces various risks including policy risks, core personnel turnover risks, and risks related to the smart city business model[4]. - The company faces risks related to policy changes, particularly as its main clients are government departments, which can impact business operations[68]. - There is a risk of core personnel loss due to market competition and technological changes, prompting the company to enhance its talent management and incentive mechanisms[69]. - The business model for smart city projects carries risks due to reliance on government funding and potential delays in project implementation[70]. - The ongoing COVID-19 pandemic has affected order acquisition and project timelines, necessitating a focus on technological innovation and customer responsiveness[74]. - The company is cautious about investment and acquisition risks, emphasizing thorough due diligence and post-investment management to mitigate potential issues[71]. Governance and Compliance - The company maintains a strong governance structure, ensuring effective risk control and investor relations management, which fosters a positive image in the capital market[44]. - The company emphasizes compliance with laws and regulations, maintaining transparency and communication with investors[85]. - The financial report for the first half of 2021 was not audited, which may affect the reliability of the financial data presented[128]. - The company did not engage in any major related party transactions during the reporting period[96][97][98][99][100][101]. - The company reported no significant asset or equity sales during the reporting period[65][66]. Shareholder Information - The total number of shares is 655,789,086, with 95.65% being unrestricted shares[113]. - The largest shareholder, Yinjian Technology Group Co., Ltd., holds 18.39% of the shares, totaling 120,599,500 shares, with 91,500,000 shares pledged[118]. - The total number of ordinary shareholders at the end of the reporting period is 47,378[117]. - The total number of restricted shares at the end of the period is 28,500,321 shares, with no shares released during the reporting period[115]. - The company has a significant portion of shares (27,813,840 shares) that are still under lock-up due to performance commitments[115]. Technological Advancements - The company has made significant advancements in technology-driven strategies, with 232 patents (including 179 invention patents) and various accolades, enhancing its competitive edge in the market[39]. - The company has a total of 34 subsidiaries included in its consolidated financial statements as of June 30, 2021, indicating a broad operational footprint[171]. - The company operates in various sectors including smart city, smart transportation, and smart healthcare, focusing on technology development and project implementation[171]. Market Position and Recognition - The company has received multiple awards, including recognition as a leading enterprise in the smart building industry and the IoT innovation product award in Zhejiang Province, reflecting its comprehensive capabilities[40]. - Active participation in major industry exhibitions has increased the company's visibility and recognition in the digital sector, further enhancing its brand value[41]. - The company has not disclosed any new product developments or market expansion strategies in the current report[118]. - Future outlook and strategic initiatives regarding market expansion or new product development were not detailed in the provided content[162].